SSShabnam Shirdel

Shabnam Shirdel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shabnam Shirdel has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Predictive power of artificial intelligence for malignant cerebral edema in stroke patients: a CT-based systematic review and meta-analysis of prevalence and diagnostic performance

    by Arezoo Shafieioun, Hossein Ghaffari, Mansoureh Baradaran, Amirhossein Rigi, Mohammad Shahir Eftekhar, Farzaneh Shojaeshafiei, Mohammad Amir Korani, Bahareh Hatami, Shabnam Shirdel, Kimia Ghanbari, et al.

    Malignant cerebral edema (MCE) is a severe complication of acute ischemic stroke, with high mortality rates. Early and accurate prediction of MCE is critical for initiating timely interventions such as decompressive hemicraniectomy. Artificial intelligence (AI) and radiomics have emerged as promising tools for predicting MCE, offering the potential to transform reactive stroke management into proactive care. However, variability in methodologies and inconsistent reporting limits the widespread adoption of these technologies. A comprehensive search of PubMed, Embase, Web of Science, and Scopus identified studies reporting on the sensitivity, specificity, and area under the curve (AUC) of AI models in MCE prediction. Data were synthesized using random-effects meta-analyses. Subgroup analyses explored the impact of study design, machine learning input type, and other key factors on diagnostic accuracy. Publication bias was assessed using Egger’s test and funnel plot analyses. Data from ten studies encompassing 1,594 unique stroke patients were included in the analysis. The pooled sensitivity and specificity of AI models for predicting MCE were 81.1% (95% CI: 73.0–87.2%) and 92.6% (95% CI: 91.2–93.9%), respectively, with an AUC of 0.939. The diagnostic odds ratio was 43.73 (95% CI: 24.78–77.15), demonstrating excellent discriminative ability. Subgroup analyses revealed higher sensitivity and specificity in prospective studies (92.0% and 93.3%) compared to retrospective studies (76.1% and 91.4%). Radiomics-based models showed slightly higher sensitivity (84.2%) compared to non-radiomics models (80.4%), though both input types achieved comparable specificity. Interestingly, patients undergoing revascularization had a higher prevalence of MCE, likely due to their more severe initial presentations. Minimal heterogeneity was observed in specificity across studies, while publication bias was noted for sensitivity estimates. AI models show excellent diagnostic performance for predicting malignant cerebral edema (MCE), offering high sensitivity and specificity. Prospective studies, radiomics integration, and multi-center collaborations enhance their accuracy. However, external validation and standardized methodologies are needed to ensure broader clinical adoption and improve outcomes for stroke patients at risk of MCE. Clinical trial number Not applicable.


  • Brain MRI findings in neurologically symptomatic COVID-19 patients: a systematic review and meta-analysis

    by Amir Masoud Afsahi, Alexander M. Norbash, Shahla F. Syed, Maya Sedaghat, Ghazaleh Afsahi, Ramin Shahidi, Zohreh Tajabadi, Mahsa Bagherzadeh-Fard, Shaghayegh Karami, Pourya Yarahmadi, et al.

    Background Coronavirus disease 2019 (COVID-19) has been associated with nervous system involvement, with more than one-third of COVID-19 patients experiencing neurological manifestations. Utilizing a systematic review, this study aims to summarize brain MRI findings in COVID-19 patients presenting with neurological symptoms. Methods Systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) checklist. The electronic databases of PubMed/MEDLINE, Embase, Scopus, and Web of Science were systematically searched for literature addressing brain MRI findings in COVID-19 patients with neurological symptoms. Results 25 publications containing a total number of 3118 COVID-19 patients with neurological symptoms who underwent MRI were included. The most common MRI findings and the respective pooled incidences in decreasing order were acute/subacute infarct (22%), olfactory bulb abnormalities (22%), white matter abnormalities (20%), cerebral microbleeds (17%), grey matter abnormalities (12%), leptomeningeal enhancement (10%), ADEM (Acute Disseminated Encephalomyelitis) or ADEM-like lesions (10%), non-traumatic ICH (10%), cranial neuropathy (8%), cortical gray matter signal changes compatible with encephalitis (8%), basal ganglia abnormalities (5%), PRES (Posterior Reversible Encephalopathy Syndrome) (3%), hypoxic-ischemic lesions (4%), venous thrombosis (2%), and cytotoxic lesions of the corpus callosum (2%). Conclusion The present study revealed that a considerable proportion of patients with COVID-19 might harbor neurological abnormalities detectable by MRI. Among various findings, the most common MRI alterations are acute/subacute infarction, olfactory bulb abnormalities, white matter abnormalities, and cerebral microbleeds.